<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01449916</url>
  </required_header>
  <id_info>
    <org_study_id>SSSP</org_study_id>
    <secondary_id>R24TW007988</secondary_id>
    <nct_id>NCT01449916</nct_id>
  </id_info>
  <brief_title>Simplified Severe Sepsis Protocol in Zambia</brief_title>
  <acronym>SSSP</acronym>
  <official_title>Improving Sepsis Diagnosis and Treatment: Simplified Severe Sepsis Protocol (SSSP)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vanderbilt University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>John E. Fogarty International Center (FIC)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Vanderbilt University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a randomized control trial assessing the impact of a simple evidence-based
      protocol for the treatment severe sepsis in Zambia. The intervention protocol consists of a
      scheduled fluid regimen, early blood culture and antibiotics, and dopamine and blood
      transfusion when necessary. It is hypothesized that the protocol will significantly decrease
      in-hospital mortality in patients with severe sepsis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In recent years, evidence-based protocols of bundled therapies have improved survival of
      severe sepsis in developed countries. However, in sub-Saharan Africa, simple therapies such
      as IV fluids and early antibiotics are frequently under-utilized. Furthermore, although
      tuberculosis is a common cause of severe sepsis in the region, accurate and timely diagnosis
      of tuberculosis-associated severe sepsis remains elusive.

      The aims of this study are (1) To assess the impact on survival of a simple evidence-based
      protocol for severe sepsis, (2) To evaluate the cost of implementation for a simplified
      severe sepsis protocol (3) To develop a clinical diagnostic score for identifying
      tuberculosis in HIV positive patients with severe sepsis (4) To assess the performance of the
      Xpert TB/RIF rapid PCR system for diagnosing tuberculosis in HIV positive patients with
      severe sepsis.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>February 2012</start_date>
  <completion_date type="Anticipated">November 2012</completion_date>
  <primary_completion_date type="Anticipated">October 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>In-hospital all cause mortality</measure>
    <time_frame>During hospitalization, expected average 14 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>28-day all-cause mortality</measure>
    <time_frame>28-day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>In-hospital all cause mortality adjusted for illness severity</measure>
    <time_frame>During hospitalization, expected average 14 days</time_frame>
    <description>Adjusted for SAPS3 score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>28-day all cause mortality adjusted for baseline illness severity</measure>
    <time_frame>28-day</time_frame>
    <description>Adjusted for SAPS3 score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cumulative adverse events</measure>
    <time_frame>During hospitalization, expected average 14 days</time_frame>
    <description>A composite outcome consisting of dopamine extravasation, dopamine-associated tissue ischemia or necrosis, iatrogenic pulmonary oedema, and transfusion-related adverse events.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Treatment cost per patient</measure>
    <time_frame>During hospitalization, expected average 14 days</time_frame>
    <description>A budget impact analysis will determine the cost of treatment per patient using a mix of direct measurements and micro-cost observation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Antibiotic changed due to culture results</measure>
    <time_frame>During hospitalization, expected average 14 days</time_frame>
    <description>The proportion of patients whose antibiotic regimen was changed due to information obtained from blood culture results.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">348</enrollment>
  <condition>Sepsis</condition>
  <condition>Severe Sepsis</condition>
  <arm_group>
    <arm_group_label>Simplified Severe Sepsis Protocol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This protocol consists of an early aggressive fluid strategy, early blood cultures and antibiotics, and, when appropriate, blood transfusion and titratable dopamine. Monitoring is based on physical exam findings.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients are managed according to admitting doctors' orders</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Simplified Severe Sepsis Protocol</intervention_name>
    <description>Early fluid protocol, early blood cultures and antibiotics; blood cultures and titrated dopamine in selected patients; monitoring based on vital signs and physical examination</description>
    <arm_group_label>Simplified Severe Sepsis Protocol</arm_group_label>
    <arm_group_label>Usual care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18 or older

          -  Suspected infection

          -  2 or more of SIRS criteria:

               -  Heart rate &gt;90/min

               -  Respiratory rate &gt;20/min

               -  Temperature &gt;= 38° C or &lt;= 36° C

               -  White blood count &gt; 12,000 or &lt; 4,000/µL

          -  1 or more of the following signs of end-organ dysfunction

               -  Systolic blood pressure &lt; 90 mm Hg

               -  Mean arterial blood pressure (MAP) &lt; 65 mm Hg

               -  Confusion/altered mentation

               -  Urine output &lt; 0.5 mL/kg/hr

               -  Creatinine increase &gt; 0.5 mg/dL

               -  Creatinine &gt; 0.5 mg/dL above upper limit of normal

               -  Platelet &lt; 100x109/L

               -  Respiratory rate &gt; 40/min

               -  Jaundice

        Exclusion Criteria:

          -  GI bleed

          -  Need for urgent surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Benjamin L Andrews, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vanderbilt University and University of Zambia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Benjamin L Andrews, MD</last_name>
    <email>lauandrews@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Teaching Hospital</name>
      <address>
        <city>Lusaka</city>
        <country>Zambia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Benjamin L Andrews, MD</last_name>
      <email>lauandrews@yahoo.com</email>
    </contact>
    <contact_backup>
      <last_name>Max Katubulushi</last_name>
      <email>mkatubulushi@yahoo.co.uk</email>
    </contact_backup>
    <investigator>
      <last_name>Benjamin L Andrews, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Shabir Lakhi, MBChBMMedMPH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Levy Muchemwa, MBChB</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Zambia</country>
  </location_countries>
  <verification_date>June 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 5, 2011</study_first_submitted>
  <study_first_submitted_qc>October 6, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 10, 2011</study_first_posted>
  <last_update_submitted>June 6, 2012</last_update_submitted>
  <last_update_submitted_qc>June 6, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 7, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Vanderbilt University</investigator_affiliation>
    <investigator_full_name>Ben Andrews</investigator_full_name>
    <investigator_title>Global Health Research Fellow</investigator_title>
  </responsible_party>
  <keyword>Sepsis</keyword>
  <keyword>Severe Sepsis</keyword>
  <keyword>Protocol</keyword>
  <keyword>Zambia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Toxemia</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>March 21, 2017</submitted>
    <returned>May 2, 2017</returned>
    <submitted>November 27, 2017</submitted>
    <returned>December 21, 2017</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

